This review highlights the intersection of neurology and cardiology in managing atrial fibrillation, emphasizing its role in stroke and cognitive decline, and discussing prophylactic strategies.
Atrial fibrillation (AF) has a huge impact on clinical stroke because it is the primary cause of cardio-embolism, which constitutes ~20% of all strokes. As a result, there is a great need to explore safer and more effective primary and secondary prophylactic agents. In this article, we discuss the overlapping issues pertaining to AF from both a neurology and cardiology standpoint. We focus on the dynamic interplay of neurovascular and cardiovascular diseases in relation to AF, traditional and novel risk factors for AF leading to stroke, impact of AF on cognitive decline, and current upstream medical and surgical options for embolism prophylaxis.
No takes yet. Share an insight, caveat, or question.
Abukhalil et al. (2013) conducted a review in Atrial Fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: